Branislav  Vajdic net worth and biography

Branislav Vajdic Biography and Net Worth

President, Director of HeartBeam

Branislav Vajdic, PhD, President and Founder of HeartBeam, Inc, combines over 30 years of experience in technology development and senior management positions. Dr. Vajdic has been deeply involved with the development of HeartBeam’s technology to fit his vision for the Company. Prior to HeartBeam from 2007 to 2010, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded company in the cardiovascular devices space. From 1984 to 2007, Dr. Vajdic was at Intel, where he held various senior management position. At Intel, Dr. Vajdic and was the designer of first Flash memory and two key inventions that enabled Flash as a product and led engineering groups responsible for Pentium 1 through Pentium 4 designs. Dr. Vajdic was awarded two Intel Achievement Awards, the highest level of award for outstanding contributions to Intel. Dr. Vajdic is author of numerous patents and publications in the fields of cardiovascular devices as well as chip design. Dr. Vajdic holds a PhD degree in Electrical Engineering from the University of Minnesota.

What is Branislav Vajdic's net worth?

The estimated net worth of Branislav Vajdic is at least $334.76 thousand as of April 16th, 2026. Dr. Vajdic owns 909,914 shares of HeartBeam stock worth more than $334,757 as of September 30th. This net worth approximation does not reflect any other investments that Dr. Vajdic may own. Learn More about Branislav Vajdic's net worth.

How do I contact Branislav Vajdic?

The corporate mailing address for Dr. Vajdic and other HeartBeam executives is 1000 CEDAR HOLLOW ROAD, MALVERN PA, 19355. HeartBeam can also be reached via phone at 610-729-7000 and via email at [email protected]. Learn More on Branislav Vajdic's contact information.

Has Branislav Vajdic been buying or selling shares of HeartBeam?

Branislav Vajdic has not been actively trading shares of HeartBeam during the last ninety days. Most recently, on Thursday, April 16th, Branislav Vajdic bought 31,250 shares of HeartBeam stock. The stock was acquired at an average cost of $0.80 per share, with a total value of $25,000.00. Following the completion of the transaction, the director now directly owns 909,914 shares of the company's stock, valued at $727,931.20. Learn More on Branislav Vajdic's trading history.

Are insiders buying or selling shares of HeartBeam?

In the last year, HeartBeam insiders bought shares 7 times. They purchased a total of 1,118,750 shares worth more than $895,000.00. In the last year, insiders at the medical research company sold shares 3 times. They sold a total of 307,146 shares worth more than $1,077,090.03. The most recent insider tranaction occured on April, 16th when CFO Tim Cruickshank bought 31,250 shares worth more than $25,000.00. Insiders at HeartBeam own 18.0% of the company. Learn More about insider trades at HeartBeam.

Information on this page was last updated on 4/16/2026.

Branislav Vajdic Insider Trading History at HeartBeam

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/16/2026Buy31,250$0.80$25,000.00909,914View SEC Filing Icon  
See Full Table

Branislav Vajdic Buying and Selling Activity at HeartBeam

This chart shows Branislav Vajdic's buying and selling at HeartBeam by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

HeartBeam Company Overview

HeartBeam logo
BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.
Read More

Today's Range

Now: $0.37
Low: $0.36
High: $0.38

50 Day Range

MA: $0.47
Low: $0.36
High: $0.59

2 Week Range

Now: $0.37
Low: $0.36
High: $4.00

Volume

4,039 shs

Average Volume

973,169 shs

Market Capitalization

$20.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A